Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 15,000 shares at $2.11 ($32K) on 2025-11-14, disclosed to the SEC on 2025-11-18.
Open-market purchase of $32k ANVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ANVS | BUY | 2025-12-08 | $194K | — | Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |